Puma Biotechnology Inc Banner Image

Puma Biotechnology Inc

  • Ticker PBYI
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Puma Biotechnology Inc Logo Image
  • 51-200 Employees
  • Based in Los Angeles, California
Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products for the treatment of various forms of cancer. Its drug candidates include PB272 (neratinib (oral)) for the treatment of advanced breast cancer patients, non-small cell lung cancer patients, and patients with HER2 mutation-positive solid tumorsMore; and PB272 (neratinib (intravenous)) for the treatment of advanced cancer patients.
4.8 / 5.0 (328)

Puma Biotechnology Inc reports have an aggregate usefulness score of 4.8 based on 328 reviews.

Puma Biotechnology Inc

Most Recent Annual Report

Puma Biotechnology Inc
MOST RECENT 2022 Annual Report and Form 10K
Add Annual Report To Cart

Older/Archived Annual Reports

Puma Biotechnology Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!